Overview

Cangrelor Neonatal PK/PD and Safety Study

Status:
Completed
Trial end date:
2019-12-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the PK/PD and safety profile of cangrelor in neonatal participants at risk of thrombosis.
Phase:
Phase 1
Details
Lead Sponsor:
Chiesi Farmaceutici S.p.A.
The Medicines Company
Treatments:
Cangrelor